GSK mother and baby homes information service

The summary documents include information on nine separate trials - vaccine trials A to G, as they are referred to in the Commission’s report, and two infant milk formula trials.

The documentation has been collated from our archives as well as other published sources to evaluate, as far as possible, the history of the vaccine or milk products after their trials were conducted by researchers in mother and baby homes.

View and download the trial summary documents

Each summary outlines the following information:

• What the trial was for – for example if it was trialling a treatment for infectious diseases such as diphtheria, tetanus or measles;
• What date the trial took place;
• The location where it took place;
• The number of participants in the trial;
• The name of those organising the trial;
• The ingredients in the vaccine;
• The dosage;
• How the vaccine was administered;
• Any side effects observed in the trial and side effects observed in later trials;
• The follow up process with trial participants after vaccination and any other comments;
• Further commercialisation and/or licensing of the product.

If you believe that you may have been a participant in a trial while resident in a mother and baby home, you can submit what’s called ‘a subject access request’ to GSK. This service will tell you what, if any, personal information GSK has in relation to you.

To make a request for access to any personal data GSK may hold, please email MotherBabyHome.SubjectAccessRequest@gsk.com providing as much of the following information as possible:

• Your full name and address;
• Your name at birth (if different);
• Your date of birth;
• Your mother’s name (including her maiden name if different);
• The name of the mother and baby home(s) you lived in, if known;
• The approximate year or years you lived at that home or homes;
• Any other information that may help in the search; and
• Whether you would prefer to receive a response by email or by post.

Once the email is sent, you will receive a response acknowledging the request. The request will be forwarded securely to a third party acting on behalf of GSK and a search of the records will be conducted to see if GSK holds any information.

Depending on the outcome of the search, you will either receive a copy of any records identified or you will be informed that no personal data was found. We will aim to respond to all requests within one month. If a request is more complex, it may take a little longer.

It is important to be aware that the records are not complete for every trial. While some of the individual clinical trial records do contain important identifying information such as names and dates of birth, this information is not available for all trials. This means it is not possible to verify the identity of every participant and part of the reason why we have also published trial summary documents with information about the development and, where applicable, the licensing history of the trial products.

GSK enhances information service for former residents of mother and baby homes

1 September 2021

GSK has established an enhanced information service for former residents of mother and baby homes regarding trials that took place between 1934 and 1973 in response to the issues raised following the publication of the Commission of Investigation’s report.

Read more